Nova Leap Health Corp.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Christopher Dobbin
- Full Time Employees
- 541
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- 7071 Bayers Road Halifax NS Canada B3L 2C2
- IPO Date
- Apr 26, 2016
- Website
- novaleaphealth.com
- Similar Companies
- Business
- Nova Leap Health Corp. (TSXV: NLH) operates as a home health care provider that acquires, manages and builds home care services companies delivering non-medical support to clients and families in the United States and Canada; core offerings encompass dementia care, companionship services, personal care encompassing bathing, dressing, grooming and activities of daily living, respite care, palliative care, meal preparation and cooking, light housekeeping, errands, transportation, medication reminders and administration, senior transitional services from hospital or rehabilitation settings, and specialized programs for veterans requiring assistance with daily activities. The company targets aging populations and families seeking in-home solutions, with operations spanning 10 U.S. states including recent entries in Florida, Kentucky and Massachusetts alongside established presence in northeastern states such as New Hampshire, Vermont, Rhode Island and Nova Scotia in Canada; founded in 2015, Nova Leap Health Corp. maintains headquarters in Halifax, Nova Scotia. In recent developments, the company closed a strategic home care acquisition in Florida in December 2024 to establish initial market presence there, followed by a January 2025 acquisition and a May 2025 closing of another home care business in Nova Scotia marking its fastest-growing segment, opened a new organic expansion office in Kentucky, executed a Massachusetts acquisition as part of re-engaged M&A activities, amended its credit agreement to access up to an additional $7 million supporting growth including $4.7 million available for acquisitions as of late 2025, and reported record Q3 2025 consolidated quarterly revenues alongside its second consecutive year of record annual adjusted EBITDA in 2024 with Q1 2025 revenues up 10.3% year-over-year.
Company News
Nova Leap Health Corp. to Highlight Record Performance at Planet MicroCap Showcase Toronto
Nova Leap Health Corp. Posts Record Q2 2026 Revenue, Income from Operating Activities and Adjusted EBITDA
Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
Nova Leap Health Corp. Posts Q1 2026 Results
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia
President & CEO Letter to Shareholders
Nova Leap Health Corp. Posts Fourth Quarter and Record Full-Year 2025 Revenues and Adjusted EBITDA
Nova Leap Health Corp. Launches Palliative Care Division In Nova Scotia Through Earth Angels Home Care
Nova Leap Health Corp. Launches Care Management Division In the United States
Nova Leap Health Corp. to Highlight Record Q2 2025 Results at Planet MicroCap Showcase Toronto
Nova Leap Health Corp. Posts Record Q2 2025 Results
Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
Nova Leap Health Corp. Posts Q1 2025 Results
Nova Leap Health Corp. announces Closing of Home Care Acquisition in Nova Scotia
President & CEO Letter to Shareholders
Nova Leap Health Corp. Posts Fourth Quarter and 2024 Annual Financial Results Including Record Adjusted EBITDA for 2nd Consecutive Year
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia
Nova Leap Health Corp. Announces Results of Special Meeting of Shareholders
Nova Leap Health Corp. Grants Stock Options
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Florida